-Solomon Sackitey
FIRST OF ALL, I WOULD LIKE TO DEDICATE A FEW “MOMENTS OF SILENCE” IN MEMORY OF APPLE COMPUTER’S CO-FOUNDER, STEVE JOBS (1955-2011).
In recent years, the impact of Information Technology on Clinical Trials has been profound, to say the least. Smart phones are now gaining momentum in the recruitment of clinical trials volunteers.
Additionally, Smart phones have been used in tracking counterfeit drugs in the developing countries and for pharmacovigilance initiatives (monitoring of post-marketing safety of drugs).
Computer Technology has been dictating the pace for the Regulation of Biopharmaceutical products in the global healthcare market.
Apple Computer, under the leadership of the late Steve Jobs, has been one of the major players in the e-Clinical and e-Healthcare World. How do you think his death will impact new drug trials worldwide, drug regulations around the world, pharmacovigilance and e-Healthcare in general?
It appears though, that Apple had been very secretive about its technological innovations. Has this hampered innovation in the Technology industry in general and the Health Informatics sector in particular? Is Apple now going to be more apt to sharing?
How about Apple’s influence in the classrooms? Great impact, very positive. How will Steve Jobs’s death impact all these?
Your take on Steve Jobs’s great loss to human development? How will Steve’s death impact Cancer Research?
We still love you, Steve and we will miss you dearly forever. May the Lord Grant You Eternal Peace!!!
GLOBAL REGULATORY AFFAIRS SPOTLIGHTS 